NCT04903782 Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
| NCT ID | NCT04903782 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sydney Children's Hospitals Network |
| Condition | Neoplastic Syndromes, Hereditary |
| Study Type | OBSERVATIONAL |
| Enrollment | 270 participants |
| Start Date | 2021-03-08 |
| Primary Completion | 2023-03-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 270 participants in total. It began in 2021-03-08 with a primary completion date of 2023-03-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assessment of the utility of family-based (trio) whole-genome sequencing for cancer predisposition testing in sequential newly diagnosed paediatric and adolescent cancer patients
Eligibility Criteria
* New diagnosis of malignancy * Age ≤ 21 years * Written informed consent Psychosocial component: * Participants (≥ 12 years) * Parent/caregiver(s) of participants * Healthcare professionals involved in the care of patients enrolled in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04903782 clinical trial?
This trial is open to participants of all sexes, up to 21 Years, studying Neoplastic Syndromes, Hereditary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04903782 currently recruiting?
Yes, NCT04903782 is actively recruiting participants. Contact the research team at SCHN-PREDICT@health.nsw.gov.au for enrollment information.
Where is the NCT04903782 trial being conducted?
This trial is being conducted at Newcastle, Australia, Sydney, Australia, Sydney, Australia.
Who is sponsoring the NCT04903782 clinical trial?
NCT04903782 is sponsored by Sydney Children's Hospitals Network. The trial plans to enroll 270 participants.